An interventional study of Active Lever Positioning Manipulation and Sham Lever Positioning Manipulation in Lumbar Disc Herniation, sponsored by The Third Affiliated hospital of Zhejiang Chinese Medical University. Not yet recruiting at 1 site in China. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-27.
Sponsored by The Third Affiliated hospital of Zhejiang Chinese Medical University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 52 studies in Intervertebral Disc Displacement with a site in China — 13 open to participants now, 14 under way, none of them phase 3. Intervertebral Disc Displacement · China.
Among the 52 studies in Intervertebral Disc Displacement with a site in China, this one is the 12th largest by planned enrollment of the 41 interventional ones that give a count, is one of 4 that started in 2026, is one of 35 with no phase, reaches primary completion later than 7 of the 13 other live ones, and was the 46th registered.
474 studies on the registry are indexed under Intervertebral Disc Displacement; 98 are open to participants now.
Browse Intervertebral Disc Displacement studies →13 of the 52 studies in Intervertebral Disc Displacement with a site in China are open now. Recruiting first, the newest first:
Fan Zhang · Sites in China
Ages 18–75
The Affiliated Hospital of Qingdao University · Sites in China
Ages 12–65
Li Xiang · Sites in China
Ages 19–65
Peking University Third Hospital · Sites in China
Ages 18–80
The Third Affiliated hospital of Zhejiang Chinese Medical University · Sites in China
Ages 20–60 · Healthy volunteers
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 48 Intervertebral Disc Displacement studies recruiting now, 20 (42%) set no upper age limit and 24 (50%) stop at 75 or younger; 3 take children under 18; 6 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
52 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 4 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 126 is above the median of 63 across 344 interventional studies indexed under Intervertebral Disc Displacement.
Median enrollment 90 across the 41 interventional studies, 120 across the 11 observational. Of the 19 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 52 has an industry lead sponsor. The 10 most frequent:
The Third Affiliated hospital of Zhejiang Chinese Medical University is the lead sponsor of 45 studies on the registry; 25 are open to participants now.
The Third Affiliated hospital of Zhejiang Chinese Medical University has 4 studies filed under Intervertebral Disc Displacement — fewer than ten, so there is no comparison to draw.
5 of the studies in Intervertebral Disc Displacement with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07161232Li XiangThe Influence of the Timing of Postoperative Rehabilitation Intervention on the Clinical Efficacy of Unilateral Biportal Endoscopic Spine System in the Treatment of Lumbar Disc Herniation | 2026-11-28 |
| NCT07531485Xi'an Honghui HospitalThe Selective Intraperineural Nerve Root Block Study | 2026-12-01 |
| NCT07250581The Affiliated Hospital of Qingdao UniversityA Randomized Trial of Annular Repair With Discectomy Versus Discectomy Alone for Lumbar Disc Herniation | 2026-12-31 |
| NCT07728149The Third Affiliated hospital of Zhejiang Chinese Medical UniversityBrain Connectomic Mechanisms of Spinal Manipulative Therapy on LDH Analgesia Based on Multimodal MRI | 2027-09 |
| NCT06591442Wuhan Union Hospital, ChinaScreening and Prospective Cohort Study of Risk Factors for Enhanced Recovery After Spinal Fusion Surgery in Advanced Age Patient | 2027-09-03 |
Add all 5 to your calendar (.ics) → With an account.
Among the 52 studies in Intervertebral Disc Displacement with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Low back and leg pain caused by lumbar disc herniation (LDH) is common. Lever positioning manipulation (LPM) is a spinal manual therapy used to relieve this pain, but how it affects the brain is unclear. This study will compare active LPM with a sham procedure and use multimodal magnetic resonance imaging (MRI) to investigate changes in brain networks associated with pain relief.
A total of 84 adults with LDH will be randomly assigned in a 1:1 ratio to active LPM or sham LPM, with three sessions per week for 12 weeks. An additional 42 age- and sex-matched healthy adults will undergo baseline assessments without treatment. Participants with LDH will be assessed before treatment, immediately after the first session, at week 6, and at week 12. Outcomes include pain intensity, lumbar function, disability, adverse events, and MRI measures of functional and structural brain connectivity. The study aims to identify brain connectomic mechanisms associated with LPM-induced analgesia.
This is a single-center, prospective, randomized, participant- and outcome-assessor-masked, sham-controlled study with a matched healthy control cohort. Eighty-four participants with lumbar disc herniation will be randomly allocated 1:1 to active lever positioning manipulation or sham lever positioning manipulation using a computer-generated block randomization sequence prepared by an independent statistician. Allocation will be concealed in sequentially numbered, opaque, sealed envelopes. Forty-two age- and sex-matched healthy controls will complete baseline clinical and MRI assessments only.
Active and sham treatments will be delivered three times weekly for 12 weeks, with approximately 20 minutes per session. The sham procedure will reproduce the treatment setting, participant position, preparatory procedures, and practitioner contact but will omit the rapid lever-pulling maneuver. Analgesics, neurotrophic drugs, sedatives, spinal manipulation, acupuncture, traction, and other therapies that could affect pain or MRI outcomes will be prohibited during the treatment period.
Participants with LDH will be assessed at baseline before randomization, immediately after the first treatment session, at week 6, and at week 12. The primary outcome is change in pain intensity measured by the Visual Analog Scale from baseline to week 12. Secondary clinical outcomes include lumbar function measured by the Japanese Orthopaedic Association score and disability measured by the Oswestry Disability Index. Multimodal MRI will be used to evaluate longitudinal changes in functional network topology, white-matter structural connectivity, and structure-function coupling. Exploratory analyses will examine gray-matter covariance and associations between clinical improvement and imaging changes. Safety will be assessed through adverse-event monitoring and vital-sign checks at each treatment session.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Patients with lumbar disc herniation (LDH):
Healthy controls:
Exclusion Criteria:
Patients with LDH:
Healthy controls:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants with lumbar disc herniation receive active lever positioning manipulation three times per week for 12 weeks, approximately 20 minutes per session. The procedure includes segment localization, stabilization, positioning to the pre-thrust point, and a rapid lever-pulling maneuver during exhalation.
Procedure: Active Lever Positioning Manipulation
Participants with lumbar disc herniation receive sham lever positioning manipulation three times per week for 12 weeks, approximately 20 minutes per session. The sham procedure reproduces the treatment setting, position, preparatory procedures, and practitioner contact but omits the rapid lever-pulling maneuver.
Procedure: Sham Lever Positioning Manipulation
Age- and sex-matched healthy adults undergo baseline clinical assessment and multimodal MRI only. They receive no study intervention and provide a reference for baseline brain connectivity measures.
Delivered three times weekly for 12 weeks, approximately 20 minutes per session, by an experienced rehabilitation practitioner. With the participant's hips and knees flexed and legs crossed, the practitioner identifies the target lumbar segment, stabilizes it with the elbow, holds the ankles, and lifts and pulls the legs upward and inward to the pre-thrust position. A rapid lever-pulling maneuver is then performed while the participant exhales.
Delivered three times weekly for 12 weeks, approximately 20 minutes per session, in the same setting and position as the active procedure. Preparatory positioning and practitioner contact are reproduced, but no rapid lever-pulling maneuver is performed. The position is held for 30 seconds with a 15-cm elastic lumbar belt placed around the lower abdomen and pelvis at L4-S1, light hand contact on the ankles, and gradual release.
Change in Pain Intensity Measured by the Visual Analog Scale (VAS)
Pain intensity will be assessed using the Visual Analog Scale (VAS). The prespecified primary endpoint is the between-group difference between active LPM and sham LPM in change from baseline to week 12. VAS will also be collected immediately after the first treatment session and at week 6.
Time frame: Baseline, immediately after the first treatment session, week 6, and week 12; primary endpoint at week 12
Change in Lumbar Function Measured by the Japanese Orthopaedic Association (JOA) Score
Lumbar neurological and functional status will be assessed using the Japanese Orthopaedic Association (JOA) score. Change from baseline will be compared between the active LPM and sham LPM groups.
Time frame: Baseline, immediately after the first treatment session, week 6, and week 12
Change in Disability Measured by the Oswestry Disability Index (ODI)
Disability related to low back pain will be assessed using the Oswestry Disability Index (ODI), a patient-reported measure of limitations in daily activities. Change from baseline will be compared between the active LPM and sham LPM groups.
Time frame: Baseline, immediately after the first treatment session, week 6, and week 12
Change in Resting-State Functional Brain Network Topology
Resting-state functional MRI will be parcellated using the 116-region Automated Anatomical Labeling atlas. Pearson correlation matrices and graph-theoretical metrics reflecting network integration, segregation, and nodal importance will quantify functional topology. Longitudinal change will be compared between active LPM and sham LPM.
Time frame: Baseline, immediately after the first treatment session, week 6, and week 12; main longitudinal comparison from baseline to week 12
Change in White-Matter Structural Connectivity
Diffusion tensor imaging will be parcellated with the 116-region Automated Anatomical Labeling atlas. Whole-brain deterministic streamline tractography will generate structural networks. Edges will be weighted by mean fractional anisotropy along streamlines connecting region pairs, with absent connections coded as zero. Longitudinal change will be compared between active LPM and sham LPM.
Time frame: Baseline, immediately after the first treatment session, week 6, and week 12; main longitudinal comparison from baseline to week 12
Change in Brain Structure-Function Coupling
Functional and white-matter structural connectivity matrices will use the same 116-region Automated Anatomical Labeling parcellation. For each participant, structure-function coupling will be quantified by the correspondence between functional and structural edge weights across the connectome. Longitudinal change will be compared between active LPM and sham LPM.
Time frame: Baseline, immediately after the first treatment session, week 6, and week 12; main longitudinal comparison from baseline to week 12
Change in Group-Level Gray-Matter Structural Covariance Networks
High-resolution T1-weighted images will be segmented, and gray-matter volume will be extracted for each Automated Anatomical Labeling region. Group-level structural covariance networks will be constructed from interregional covariance in gray-matter volume after adjustment for relevant demographic and anatomical covariates. This exploratory measure will be interpreted at the group level rather than as an individual biomarker.
Time frame: Baseline, immediately after the first treatment session, week 6, and week 12; exploratory longitudinal comparison from baseline to week 12
Association Between Changes in Connectome Metrics and Clinical Outcomes
Exploratory Spearman rank correlation analyses will assess whether changes in individual-level functional network topology, white-matter structural connectivity, and structure-function coupling are associated with changes in Visual Analog Scale, Japanese Orthopaedic Association, and Oswestry Disability Index scores. The Benjamini-Hochberg false discovery rate procedure will control for multiple comparisons.
Time frame: Baseline through week 12; change scores for the main exploratory association calculated from baseline to week 12
Incidence of Adverse Events
The number and proportion of participants experiencing adverse events will be recorded. Any undesirable medical occurrence will be documented regardless of causal relationship, and severity and relationship to the intervention will be assessed. Vital signs and treatment-related discomfort or safety concerns will be checked at each treatment session; serious adverse events will be reported according to institutional requirements.
Time frame: From the first treatment session through the end of the 12-week intervention
Plan to share: Undecided
No publications or documents are linked to this record.
Start is estimated for Jul 2026; primary completion for Sep 2027, 14 months later.
Of 178 non-industry interventional studies with no phase under Intervertebral Disc Displacement, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 23. This study's planned 14 months is above that.
Counting every sponsor, half of 191 studies reached it within 12 months; a quarter within 5 and three quarters within 27.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Intervertebral Disc Displacement →
The Third Affiliated hospital of Zhejiang Chinese Medical University